Craig Mull - Cipher Pharmaceuticals Interim Chairman

CPHRFDelisted Stock  USD 2.57  0.00  0.00%   

Chairman

Mr. Craig J. Mull is Chairman of the Board of the Company. Mr. Mull has extensive experience in the Canadian healthcare industry, including holding the position of COO with CML HealthCare where he was responsible for the daytoday operations. During his tenure at CML, Mr. Mull was part of a small executive team that grew the company from a market cap of 100 million to over 1.2 billion. Mr. Mull also played an integral role in planning and structuring Cipher initial public offering as it was spun out of CML. since 2019.
Tenure 5 years
Phone905 602 5840
Webhttps://www.cipherpharma.com

Cipher Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of 0.149 % which means that it generated a profit of $0.149 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2403 %, meaning that it generated $0.2403 on every $100 dollars invested by stockholders. Cipher Pharmaceuticals' management efficiency ratios could be used to measure how well Cipher Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.
Cipher Pharmaceuticals has accumulated 507 K in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Cipher Pharmaceuticals has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Cipher Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Cipher Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cipher Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cipher to invest in growth at high rates of return. When we think about Cipher Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada. Companhia Siderurgica is traded on OTC Exchange in the United States. Cipher Pharmaceuticals [CPHRF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. Cipher Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.

Management Performance

Cipher Pharmaceuticals Leadership Team

Elected by the shareholders, the Cipher Pharmaceuticals' board of directors comprises two types of representatives: Cipher Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cipher. The board's role is to monitor Cipher Pharmaceuticals' management team and ensure that shareholders' interests are well served. Cipher Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cipher Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Bryan Jacobs, Chief Officer
Craig Mull, Interim Chairman
Emilio Presti, Marketing Sales
Diane Gajewczyk, VP Affairs
Chuoru Li, Co Controller
David Miller, Director Fin

Cipher Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Cipher Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in Cipher OTC Stock

If you are still planning to invest in Cipher Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cipher Pharmaceuticals' history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios